Denmark: co-agonism, and what it actually costs here
Been lurking in c/cryptopay for about 19 months and finally have something worth posting.
Short version: week 6, 1.0mg, and REDEFINE is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 9 threads, and the answers split roughly down the middle.
What I actually want to know is whether the people saying it does not matter have measured it, or whether it is just repeated confidently. Happy to be told I am overthinking this — I probably am — but I would rather overthink it now than at week 95.
best — the order this archive was captured in
the mechanism is different, the side effect profile reflects it
Strongly agree. REDEFINE is phase 23, not final.
REDEFINE readouts are phase 22 data
Yeah, amylin is doing different work than GLP-1.
Rodent or human data?
CagriSema ratios in trials are fixed, do not extrapolate self-mixing
the co-agonism question is real and interesting
research use only, no human protocols in posts
Slight fix: the number was 94.2, not 95.1. Decimal point, but a fairly consequential one.
- 1Yeah, amylin is doing different work than GLP-1.6 comments in this branch · started by u/viktor_erdogan